|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000150 USD | +50.00% |
|
0.00% | -75.00% |
| 05-29 | Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 05-28 | Stemtech Corporation Auditor Raises 'Going Concern' Doubt | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 207K | - | - | - | - | - |
| 62.21B | |||||
| 59.45B | |||||
| 38.9B | |||||
| 36.4B | - | ||||
| 29.52B |
- Stock Market
- Stocks
- STEK Stock
- Charts Stemtech Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
